Biodegradable Stent Crystallinity Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current biodegradable stents lack sufficient strength and controlled degradation profiles, which can lead to inadequate support and persistence in the body lumens, necessitating improved fabrication methods to enhance their structural integrity and longevity.

Innovation Solution

The use of heat treatment to modify biodegradable polymers by controlling crystallinity, glass transition temperature, and molecular weight, allowing for enhanced strength and controlled biodegradation, with specific temperature and time parameters to achieve desired properties such as radial expansion and sustained support of body lumens.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of stationary object

If biodegradable polymers are used to make stents, then the stents can degrade over time in the body, but the stents lack sufficient strength and structural integrity

Engineering Contradiction:
Improvebiodegradation timeVSAvoidradial strength
Core Design Contradiction:
Duration of action of stationary objectVSStrength

Solution Approach 1:

The patent applies heat treatment to change the physical and chemical parameters of the biodegradable polymer, specifically controlling crystallinity, glass transition temperature, and molecular weight. This transforms the polymer properties to achieve both sufficient strength for stent support and controlled degradation rates, resolving the contradiction between durability and biodegradability

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses composite polymeric materials with controlled crystalline and amorphous phases. The crystalline regions provide structural strength and controlled degradation, while the amorphous regions allow for flexibility and radial expansion. This composite structure enables the stent to maintain strength during the required period while ensuring eventual biodegradation

Inventive Principle:
Principle #40Composite materials

2Strength

If heat treatment is applied to increase polymer crystallinity, then the stent strength increases, but the fabrication process becomes more complex

Engineering Contradiction:
Improvestent strengthVSAvoidfabrication process complexity
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The patent performs heat treatment during the stent fabrication process itself, before implantation. By controlling crystallinity and other properties during manufacturing, the complex treatment is done in advance, simplifying the overall process while ensuring the stent has the required strength characteristics before being deployed in the body

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If the stent is made to expand radially to support body lumens, then the stent provides adequate support, but the stent may fracture due to insufficient strength

Engineering Contradiction:
Improveradial expansion capabilityVSAvoidfracture resistance
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent controls the glass transition temperature and molecular weight of the polymer through heat treatment. These parameter changes enable the stent to achieve adequate radial expansion at body temperature while maintaining sufficient strength and fracture resistance, as the polymer transitions from a glassy to a rubbery state allowing expansion without breaking

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The treated biodegradable stents exhibit improved radial strength and controlled expansion, maintaining structural integrity for extended periods while ensuring biodegradation, thus providing effective support to body lumens without fracture.

Implementation Method 1

The use of heat treatment to modify biodegradable polymers by controlling crystallinity, glass transition temperature, and molecular weight

Methodology Applied
Scientific EffectHeat treatment: Heat Treatment

Implementation Method 2

controlling crystallinity

Methodology Applied
Scientific EffectCrystallization: Crystallisation

Implementation Method 3

glass transition temperature

Methodology Applied
Scientific EffectGlass transition:

Implementation Method 4

biodegradable polymers which degrade by hydrolysis and other reaction mechanisms in the vascular or other luminal environment over time

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Data Source

PatentUS8636792B2Biodegradable endoprostheses and methods for their fabrication
Publication Date: 2014.01.28 ELIXIR MEDICAL CORP
  • US8636792B2 patent drawing
  • US8636792B2 patent drawing
  • US8636792B2 patent drawing

AI summary

The disclosure provides biodegradable implantable devices such as a stent comprising a biodegradable polymeric wherein the polymeric material is treated to control crystallinity and/or Tg. The stent is capable to expand at body temperature from a crimped configuration to a deployed diameter and have sufficient strength to support a body lumen.